Cargando…
Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS
Ibrutinib, orelabrutinib, and zanubrutinib are all Bruton’s tyrosine kinase inhibitors, which have greatly improved the treatment of B-cell malignancies. In this study, an LC-MS/MS method was developed and validated for the determination of orelabrutinib, zanubrutinib, ibrutinib, and its active meta...
Autores principales: | Sun, Lu-Ning, Zhao, Yang, Qian, Zhou-Yi, Chen, Xiang-Long, Ma, Hong, Guo, Yu-Jiao, Shen, Hao, Wang, Yong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920560/ https://www.ncbi.nlm.nih.gov/pubmed/36770870 http://dx.doi.org/10.3390/molecules28031205 |
Ejemplares similares
-
Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics
por: Liu, Ya-nan, et al.
Publicado: (2022) -
Simultaneous determination of clopidogrel, 2-oxo-clopidogrel, and the thiol metabolite of clopidogrel in human plasma by LC-MS/MS
por: Xu, Lei, et al.
Publicado: (2022) -
Simultaneous Determination of RDX and HMX in Rat Plasma by LC-MS/MS and its Applications
por: Zhang, Xi, et al.
Publicado: (2022) -
Simultaneous Determination of Columbianadin and Its Metabolite Columbianetin in Rat Plasma by LC-MS/MS: Application to Pharmacokinetics of Columbianadin after Oral Administration
por: Li, Jin, et al.
Publicado: (2018) -
Determination of asenapine in presence of its inactive metabolites in human plasma by LC-MS/MS
por: Patel, Nirav P., et al.
Publicado: (2018)